ホーム > 市場調査レポート > バイオテクノロジー > バイオマテリアル > 米国におけるヒアルロン酸ベースのバイオマテリアル市場
カテゴリ
バイオテクノロジー (1630)
オーダーメイド医療 (51)
ゲノム創薬 (203)
バイオマーカー (158)
バイオマテリアル (54)
バイオ機器 (385)
遺伝子療法/RNAi (103)
抗体/免疫 (194)
再生医療 (122)
分子標的療法 (132)
市場調査レポート

米国におけるヒアルロン酸ベースのバイオマテリアル市場

U.S. Markets for Biomaterial Applications of Hyaluronic Acid (HA)

発行 Frost & Sullivan
出版日 2004年09月 商品コード 24085
ページ情報 英文  
価格
こちらの商品の販売は終了いたしました。

当商品の販売は、2011年07月19日を持ちまして終了しました。

原文目次

Research Overview

Hyaluronic Acid-based Biomaterials Pervade the Healthcare Industry

Hyaluronic acid (HA)-based biomaterials have wide-ranging applications in the healthcare industry. The materials derived from HA are being used to relieve the pain of knee osteoarthritis, in cataract surgeries, in abdominal and pelvic surgeries, and as a dermal filler to erase facial wrinkles. Moreover, an aging population, several product innovations, and underserved end-user segments are creating a huge market for HA-based biomaterials. Some existing end users include rheumatologists, ophthalmologists, plastic and reconstructive surgeons, anti-adhesive wound care specialists, and gynecologists.

This Frost & Sullivan strategic analysis service provides an overview of and an outlook for the U.S. biomaterial applications of hyaluronic acid. The study is segmented into viscosupplementation products for osteoarthritis, viscoelastic products for ophthalmic applications, facial aesthetic implants, and post-surgical anti-adhesion barriers. It enables the development of growth strategies to enhance companies’ market shares and revenue.

HA-based Biomaterials Need a Dose of Innovation to Stay Ahead

Many market segments where HA-based biomaterials have become firmly entrenched are facing increasing reimbursement pressure from Medicare and other healthcare providers. An example is the lower reimbursements for physicians for cataract surgeries, who, in turn, want reduced prices for HA-based viscoelastics. Medicare is also cutting reimbursements of viscosupplementation procedures using HA-based material for knee osteoarthritis. These market segments have not seen significant recent innovation with HA-based biomaterials. The market also needs to fight price erosion by adding value to its products.

Some market participants are already planning to develop the next generation of viscosupplements as good carriers for drug delivery. Medical device manufacturers can also fund research to unravel the mechanism of viscosupplements. "Once this is done, it will boost physician confidence leading to increased use of this procedure," says the analyst. Product manufacturers and marketers are also likely to ensure that their products maintain the value-to-price ratio in order to gain wide customer appeal.

Demand Expected to be Buoyed by Aging Baby Boomers

The number of people above 65 years is expected to more than double from 35 million in 2000 to 71 million in 2020 in the United States. People in this age group will be entering a stage where the incidence of osteoarthritis, cataract, and facial wrinkles increases. HA-based biomaterials have a significant role to play in the treatment of all these afflictions. Thus, the demand for HA-based biomaterials is expected to be spurred by the aging demographics.

Since the knee osteoarthritis patient population is expected to increase by 26 percent from 15 million in 2000 to 19 million in 2010, viscosupplements can expect an escalation in demand. Apart from a huge market for osteoarthritis medication, the post-surgical anti-adhesion barrier market also carries a huge potential. Internal adhesions after abdominal surgeries can cause problems, such as bowel obstruction and pain. "Due to the critical nature of these complications, surgeons are demanding anti-adhesion barriers that perform consistently," notes the analyst. Adhesion lysis surgeries are performed more frequently on those above 65 years than on younger age groups.

Frost & Sullivan Growth Partnership Service

Based on extensive and in-depth research, real-world consulting work, and new theories tested in hundreds of companies across many industries, Frost & Sullivan has evolved its Growth Partnership Services (GPS) program that provides established and emerging firms with powerful growth visions. Moving beyond token mission statements, GPS provides an actionable vision to growth consulting partners by illustrating how key intelligence and strategic research based on defined goals can guide day-to-day behavior and overall company direction. The foundation of Frost & Sullivan's GPS includes:

  • Assisting companies to reach their full potential in the core business
  • Providing growth strategies to help companies expand into related businesses
  • Preemptively redefining the core business during market turbulence
  • Applying the Frost & Sullivan framework to identify and address common mistakes resulting from misaligned corporate strategies
  • Recommending growth management strategies through continuous partnership

To maximize the potential for growth within a firm’s internal and external environment, Frost & Sullivan consultants can facilitate the creation of strategic programs that deliver improved market success. Frost & Sullivan’s strengths lie in combining strategic understanding with market expertise and applying these with absolute commitment to its clients’ growth.

1 TOTAL HYALURONIC ACID-BASED BIOMATERIALS MARKETS

  • Executive Summary and Overview
    • Executive Summary
    • Overview
    • Major Participants in this Industry
  • Research Segmentation
    • Segmentation by Product
    • Segmentation by End User
  • Forecasts and Trends
    • Market Drivers
    • Market Challenges
    • Revenue Forecasts
  • Frost & Sullivan Market Engineering Awards
    • Frost & Sullivan Award for Product Differentiation Innovation
    • Frost & Sullivan Award for Entrepreneurial Company
    • Frost & Sullivan Award for Product Line Strategy
    • Frost & Sullivan Award for Competitive Strategy Leadership

2 OSTEOARTHRITIS VISCOSUPPLEMENTATION PRODUCTS MARKET

  • Overview
    • Development
    • Description
    • Market Drivers
    • Market Challenges and Strategies
  • Osteoarthritis Viscosupplementation Forecasts and Trends
    • Assumptions
    • Procedure Forecast
    • Pricing Forecast
    • Revenue Forecast
  • Osteoarthritis Viscosupplementation Competitive Analysis
    • Market Share Analysis
    • Genzyme and Wyeth Partnership
    • Fidia and Sanofi-Synthelabo Partnership
    • Seikagaku and Smith & Nephew Partnership
    • Anika Therapeutics and Ortho Biotech Partnership

3 OPHTHALMIC VISCOELASTIC PRODUCTS MARKET

  • Overview
    • Development
    • Description
    • Market Drivers
    • Market Challenges and Strategies
  • Opthalmic Viscoelastics Forecasts and Trends
    • Assumptions
    • Unit Shipment Forecasts
    • Pricing Forecasts
    • Revenue Forecasts
  • Ophthalmic Viscoelastics Competitive Analysis
    • Market Share Analysis
    • Alcon
    • Advanced Medical Optics (AMO)
    • Bausch & Lomb

4 FACIAL AESTHETIC IMPLANTS MARKET

  • Overview
    • Development
    • Description
    • Market Drivers
    • Market Challenges and Strategies
  • Facial Aesthetics Forecasts and Trends
    • Assumptions
    • Unit Shipment Forecasts
    • Pricing Forecasts
    • Revenue Forecasts
  • Facial Aesthetics Competitive Analysis
    • Market Share Analysis
    • Inamed Corporation
    • Medicis Pharmaceutical Corporation

5 POST-SURGICAL ANTI-ADHESION BARRIERS MARKET

  • Overview
    • Development
    • Description
    • Market Drivers
    • Market Challenges and Strategies
  • Forecasts and Trends
    • Assumptions
    • Unit Shipment Forecasts
    • Pricing Forecasts
    • Revenue Forecasts
  • Competitive Analysis
    • Market Share Analysis
    • Genzyme

6 DECISION SUPPORT TABLES

  • Statistics on Asian Countries
    • Australia
    • China
    • India
    • Japan
    • South Korea
Back to Top